US Stock MarketDetailed Quotes

QTRX Quanterix

Watchlist
  • 16.920
  • +0.430+2.61%
Close May 2 16:00 ET
  • 16.920
  • 0.0000.00%
Post 16:02 ET
647.14MMarket Cap-19674P/E (TTM)

About Quanterix Company

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Company Profile

SymbolQTRX
Company NameQuanterix
Listing DateDec 7, 2017
Issue Price15.00
Founded2007
CEODr. Masoud Toloue, PhD
MarketNASDAQ
Employees441
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressBuilding 1,900 Middlesex Turnpike
CityBillerica
ProvinceMassachusetts
CountryUnited States of America
Zip Code01821
Phone1-617-301-9400
Websitehttp://www.quanterix.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Masoud Toloue, PhD
  • President, Chief Executive Officer and Director
  • 5.44M
  • Vandana Sriram
  • Chief Financial Officer and Principal Accounting Officer
  • 1.10M
  • Dr. Martin D. Madaus,PhD
  • Chairman of the Board
  • 275.00K
  • Brian J. Blaser
  • Independent Director
  • 445.79K
  • William P. Donnelly
  • Independent Director
  • 418.58K
  • Paul M. Meister
  • Independent Director
  • 259.96K
  • Karen A. Flynn
  • Independent Director
  • 251.63K
  • Laurie J. Olson
  • Independent Director
  • 255.00K
  • Dr. David R. Walt,PhD
  • Independent Director
  • 247.25K
  • Sarah E. Hlavinka
  • Independent Director
  • 259.96K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg